Population Pharmacokinetics of Prednisolone in Relation to Clinical Outcome in Children With Nephrotic Syndrome-Reference-Cited by-同舟云学术

Population Pharmacokinetics of Prednisolone in Relation to Clinical Outcome in Children With Nephrotic Syndrome

Published:2016-08 Issue:4 Volume:38 Page:534-545
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Teeninga Nynke,Guan Zheng,Stevens Jasper,Kist-van Holthe Joana E.,Ackermans Mariëtte T.,van der Heijden Albert J.,van Schaik Ron H. N.,van Gelder Teun,Nauta Jeroen

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference48 articles.

1. Nephrotic syndrome in childhood;Eddy;Lancet,2003

2. Corticosteroid therapy for nephrotic syndrome in children;Hodson;Cochrane Database Syst Rev.,2007

3. Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome;Teeninga;J Am Soc Nephrol.,2013

4. Influence of age at onset on the outcome of steroid-sensitive nephrotic syndrome;Kabuki;Pediatr Nephrol.,1998

5. The pediatric nephrotic syndrome spectrum: clinical homogeneity and molecular heterogeneity;Schachter;Pediatr Transpl.,2004

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and Pharmacodynamics of Systemic Corticosteroids in Autoimmune and Inflammatory Diseases: A Review of Current Evidence;Clinical Pharmacokinetics;2024-09-12

2. Corticosteroid therapy for nephrotic syndrome in children;Cochrane Database of Systematic Reviews;2024-08-22

3. Saliva monitoring of prednisolone in children with first onset steroid‐sensitive nephrotic syndrome: Is it possible?;British Journal of Clinical Pharmacology;2024-04-10

4. Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study;Journal of Nephrology;2022-04-02

5. In vitro assessments predict that CYP3A4 contributes to a greater extent than CYP3A5 to prednisolone clearance;Basic & Clinical Pharmacology & Toxicology;2021-09-24